2014
DOI: 10.1016/j.placenta.2013.12.010
|View full text |Cite
|
Sign up to set email alerts
|

Can we fix it? Evaluating the potential of placental stem cells for the treatment of pregnancy disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
33
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 33 publications
(33 citation statements)
references
References 57 publications
0
33
0
Order By: Relevance
“…However, experimental studies are hampered by ethical constraints to obtain tissues from early human gestation as well as difficulties in establishing self-renewing human trophoblast stem and progenitor cells from trophoblast isolates (34)(35)(36). As a consequence, alternative models, such as bone morphogenetic protein (BMP)-treated human ESCs (hESCs), have been developed, allowing in vitro formation of the trophoblast lineage (37,38).…”
Section: Discussionmentioning
confidence: 99%
“…However, experimental studies are hampered by ethical constraints to obtain tissues from early human gestation as well as difficulties in establishing self-renewing human trophoblast stem and progenitor cells from trophoblast isolates (34)(35)(36). As a consequence, alternative models, such as bone morphogenetic protein (BMP)-treated human ESCs (hESCs), have been developed, allowing in vitro formation of the trophoblast lineage (37,38).…”
Section: Discussionmentioning
confidence: 99%
“…The SM10 cell line is derived from the labyrinth layer of the mouse placenta, which is primarily involved in the transport of nutrients, such as glucose and amino acids, between the mother and the growing baby [3][4][5]. Proper development of the placenta is crucial for maintaining a healthy pregnancy, and abnormal development of the labyrinthine lineage could lead to reduced or altered transport of nutrients, which has been implicated in pregnancy-associated disorders such as preeclampsia, IUGR, and placental insufficiency [5][6][7][8].…”
Section: Fig 6 Ampk Knockdown Inhibits Glucose Transport (A)mentioning
confidence: 99%
“…Placental abnormalities have been implicated in a number of pregnancy-associated disorders such as preeclampsia, intrauterine growth restriction (IUGR), and placental insufficiency [6][7][8]. The possible effects of these placental disorders are not restricted to the health of the baby early in life, but can also persist into adulthood.…”
Section: Introductionmentioning
confidence: 99%
“…Umbilical cord and decidua are important sources of MSCs in the maternal‐fetal interface [Schwab and Gargett, ; Cutler et al, ], in which several regions of umbilical cord have MSCs, including Wharton's jelly, artery, vein or cord lining [Mennan et al, ]. Our previous studies showed that both umbilical cord and decidua MSCs present slow proliferation, aberrant levels of cytokines, decreased angiogenesis‐regulation ability and abnormal immunoregulation in PE [Hwang et al, ; Li et al, ; James et al, ; Chen et al, ; Zhao et al, ]. Furthermore, we used normal MSCs to treat PE‐like mouse and got the ideal therapeutic effect [Liu et al, ].…”
mentioning
confidence: 99%